News
Overview
Regulatory News
Latest webfg news
Hutchmed announces progress, hits milestone with lung cancer treatment
02 Jan
Hutchmed to receive $10m milestone payment from partner Takeda
13 Dec
Hutchmed lung cancer therapy gets breakthrough designation in China
12 Dec
Hutchmed endometrial cancer treatment gets conditional approval in China
03 Dec
Hutchmed partner launches Fruzaqla in Japan
22 Nov
Hutchmed to receive $20m Fruzaqla milestone payment
31 Oct
Hutchmed reports positive results from AstraZeneca lung cancer collaboration
16 Oct
Hutchmed partner Takeda gets Japanese approval for Fruzaqla
24 Sep
Hutchmed to present new and updated clinical trial data
09 Sep
Hutchmed withdraws supplemental new drug application in China
30 Aug
Oncology revenue drives first-half growth for Hutchmed
31 Jul
Hutchmed gets tazemetostat new drug application approved in China
04 Jul
Hutchmed partner gets European approval for fruqintinib
24 Jun
Hutchmed publishes positive sovleplenib trial results
17 Jun
Hutchmed China launches two cancer treatment trials
14 May
Hutchmed China to make several presentations at cancer research meeting
05 Apr
Hutchmed endometrial cancer treatment gets priority review in China
02 Apr
Hutchmed cancer treatment indication accepted for review in China
28 Mar
Hutchmed partner Inmagene exercises options over two drug candidates
02 Feb
Hutchmed's 'Elunate' approved under new Hong Kong rules
30 Jan
«
2024-09
2024-10
2024-11
2024-12
2025-01